SSGJ-709
/ 3SBio
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 05, 2025
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | N=10 ➔ 15
Enrollment change • Oncology • Solid Tumor
June 11, 2025
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1